New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 7, 2014
07:34 EDTNSTGNanoString launches nCounter PanCancer Pathways Panel
NanoString Technologies announced the launch of the nCounter PanCancer Pathways Panel, a highly-multiplexed, digital gene expression assay that offers a way for translational researchers to investigate cancer biology across all major cancer pathways. A growing body of research has demonstrated that a pathway-based approach to the analysis of gene expression provides a framework for understanding the changes between the biology of different cancers and cancer subtypes. From a single tube, the PanCancer Pathways Panel simultaneously analyzes of all of the key cancer pathways: PI3K, STAT, MAPK, TGF, Notch, Hedgehog, Wnt, Apoptosis, Cell Cycle, RAS, Chromatin Modification, Transcriptional Regulation and DNA Damage Control. Processing samples on the nCounter Analysis System takes just 15 minutes of hands-on time and generates reproducible data, representing a solution for studying cancer.
News For NSTG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 14, 2014
15:43 EDTNSTGNanoString management to meet with Piper Jaffray
Subscribe for More Information
November 12, 2014
07:22 EDTNSTGAssociation of Molecular Pathology is holding annual meeting
2014 Annual Meeting of AMP is being held in National Harbor, Maryland on November 12-15.
November 10, 2014
10:04 EDTNSTGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:18 EDTNSTGNanoString initiated with an Overweight at Morgan Stanley
Target $16.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use